Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Jacob

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Cardiovascular Endocrinology|April 11, 2017
'Knowing what Matters in diabetes: Healthier below 7': results of the campaign's first 10 years (part 2), participants without known diabetes historyStephan Jacob, Andrea Klimke-Huebner, Franz W Dippel, et al.
Diabetes, Obesity & Metabolism|August 14, 2025
Global cardiometabolic alliance: A clinical and research initiative addressing the 21st century pandemic of insulin resistance-associated diseaseRobert H Eckel, Andrew J Krentz, Stephan Jacob, et al.
Cardiovascular Endocrinology|April 11, 2017
'Knowing what matters in diabetes: healthier below 7': results of the campaign's first 10 years (part 1): participants with known type 2 diabetesStephan Jacob, Andrea Klimke-Hübner, Franz-Werner Dippel, et al.
Diabetes, Obesity & Metabolism|May 31, 2019
Triple therapy with low-dose dapagliflozin plus saxagliptin versus dual therapy with each monocomponent, all added to metformin, in uncontrolled type 2 diabetesJulio Rosenstock, Shira Perl, Eva Johnsson, et al.
Atherosclerosis|November 26, 2011
Ezetimibe alone and in combination lowers the concentration of small, dense low-density lipoproteins in type 2 diabetes mellitusKarl Winkler, Stephan Jacob, Tina Müller-Schewe, et al.
Journal of Lipid Research|October 17, 2002
RetractionMichael Stumvoll, Hans Günther Wahl, Stephan Jacob, et al.
Health and Quality of Life Outcomes|June 10, 2015
Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents--a randomized, prospective, crossover, open clinical trialNorbert Hermanns, Bernd Kulzer, Thomas Kohlmann, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 4, 2023
Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) GermanyMarkus Menzen, Tina Landsvig Berentzen, Andrei-Mircea Catarig, et al.
Diabetes & Vascular Disease Research|January 8, 2013
Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studiesThomas Forst, Markolf Hanefeld, Stephan Jacob, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|October 31, 2015
Normal values for intima-media thickness of the common carotid artery--an update following a novel risk factor profilingElko Randrianarisoa, Roderich Rietig, Stephan Jacob, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Cardiovascular Endocrinology|April 11, 2017
'Knowing what Matters in diabetes: Healthier below 7': results of the campaign's first 10 years (part 2), participants without known diabetes historyStephan Jacob, Andrea Klimke-Huebner, Franz W Dippel, et al.
Diabetes, Obesity & Metabolism|August 14, 2025
Global cardiometabolic alliance: A clinical and research initiative addressing the 21st century pandemic of insulin resistance-associated diseaseRobert H Eckel, Andrew J Krentz, Stephan Jacob, et al.
Cardiovascular Endocrinology|April 11, 2017
'Knowing what matters in diabetes: healthier below 7': results of the campaign's first 10 years (part 1): participants with known type 2 diabetesStephan Jacob, Andrea Klimke-Hübner, Franz-Werner Dippel, et al.
Diabetes, Obesity & Metabolism|May 31, 2019
Triple therapy with low-dose dapagliflozin plus saxagliptin versus dual therapy with each monocomponent, all added to metformin, in uncontrolled type 2 diabetesJulio Rosenstock, Shira Perl, Eva Johnsson, et al.
Atherosclerosis|November 26, 2011
Ezetimibe alone and in combination lowers the concentration of small, dense low-density lipoproteins in type 2 diabetes mellitusKarl Winkler, Stephan Jacob, Tina Müller-Schewe, et al.
Journal of Lipid Research|October 17, 2002
RetractionMichael Stumvoll, Hans Günther Wahl, Stephan Jacob, et al.
Health and Quality of Life Outcomes|June 10, 2015
Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents--a randomized, prospective, crossover, open clinical trialNorbert Hermanns, Bernd Kulzer, Thomas Kohlmann, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 4, 2023
Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) GermanyMarkus Menzen, Tina Landsvig Berentzen, Andrei-Mircea Catarig, et al.
Diabetes & Vascular Disease Research|January 8, 2013
Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studiesThomas Forst, Markolf Hanefeld, Stephan Jacob, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|October 31, 2015
Normal values for intima-media thickness of the common carotid artery--an update following a novel risk factor profilingElko Randrianarisoa, Roderich Rietig, Stephan Jacob, et al.
Pageof 5